The effect of a single intracavernous injection of autologous adipose-derived stem cells in patients with erectile dysfunction

The effect of a single intracavernous injection of autologous adipose-derived stem cells in patients with erectile dysfunction following radical cystectomy - EIIADSC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043103

Enrollment

Registered

2021-01-22

Start date

2018-01-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile dysfunction

Interventions

Singleintracavernous Adipose stem cell injection+ phosphodiesterase 5 inhibitors (tadalafil 5mg daily) phosphodiesterase 5 inhibitors (tadalafil 5mg daily)

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Potent male before radical cystectomy Patients with severe erectile dysfunction when entering the study

Exclusion criteria

Exclusion criteria: Impotent male before radical cystectomy

Design outcomes

Primary

Measure	Time frame
Assess the erectile function of the study groups: the control group and the treatment group Assess the safety of adipose stem cell in the treatment group	—

Countries

Asia(except Japan)

Contacts

Public ContactMohamad Moussa

Al Zahraa Hospital Urology

mohamadamoussa@hotmail.com009613964412

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026